Therapeutic Asset Ratings
567 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Nivolumab
Metastatic Malignant Neoplasm
Fred Hutchinson Cancer Center
P3
BB
(64)
Nivolumab
Urothelial Carcinoma
Fred Hutchinson Cancer Center
P3
BB
(64)
Pralatrexate
T-Cell Non-Hodgkin Lymphoma
Fred Hutchinson Cancer Center
P3
BB
(64)
Rapamycin
Waldenstrom Macroglobulinemia
Fred Hutchinson Cancer Center
P3
BB
(64)
Allogeneic Cd34+-Enriched And Cd45Ra-Depleted Pbscs
Myeloproliferative Neoplasm
Fred Hutchinson Cancer Center
P2
BB
(64)
Bendamustine
T-Cell Non-Hodgkin Lymphoma
Fred Hutchinson Cancer Center
P2
BB
(64)
Epirubicin
Stage IV Bladder Cancer AJCC v8
Fred Hutchinson Cancer Center
P2
BB
(64)
Epirubicin
Stage IV Ureter Cancer AJCC v8
Fred Hutchinson Cancer Center
P2
BB
(64)
METHOTREXATE
Bone Marrow Failure Syndrome
Fred Hutchinson Cancer Center
P2
BB
(64)
Pembrolizumab
Urinary Bladder Cancer
Fred Hutchinson Cancer Center
P2
BB
(64)
Pembrolizumab
Stage IV Bladder Cancer AJCC v8
Fred Hutchinson Cancer Center
P2
BB
(64)
Pembrolizumab
Ureter Cancer
Fred Hutchinson Cancer Center
P2
BB
(64)
Thiotepa
Congenital Amegakaryocytic Thrombocytopenia
Fred Hutchinson Cancer Center
P2
BB
(64)
VINCRISTINE SULFATE
B-Cell Chronic Lymphocytic Leukemia
Fred Hutchinson Cancer Center
P2
BB
(64)
CARMUSTINE
Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Fred Hutchinson Cancer Center
P3
B
(63)
FILGRASTIM
Mixed Phenotype Acute Leukemia
Fred Hutchinson Cancer Center
P3
B
(63)
FILGRASTIM
Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Fred Hutchinson Cancer Center
P3
B
(63)
Nivolumab
Colorectal Cancer
Fred Hutchinson Cancer Center
P3
B
(63)
Busulphan
HIV Infection
Fred Hutchinson Cancer Center
P2
B
(63)
CYCLOSPORIN A
Acute Leukemia
Fred Hutchinson Cancer Center
P2
B
(63)
Ibrutinib
Prolymphocytic Leukemia
Fred Hutchinson Cancer Center
P2
B
(63)
Mitoxantrone
Chronic Myelomonocytic Leukemia
Fred Hutchinson Cancer Center
P2
B
(63)
Nivolumab
Clinical Stage IV Cutaneous Merkel Cell Carcinoma AJCC v8
Fred Hutchinson Cancer Center
P2
B
(63)
Nivolumab
Colorectal Carcinoma
Fred Hutchinson Cancer Center
P2
B
(63)
Nivolumab
Her2-Receptor Negative Breast Cancer
Fred Hutchinson Cancer Center
P2
B
(63)
Showing 126 to 150 of 567 assets
Previous
Page 6 of 23
Next